Investors Encouraged to Join Class Action Against Picard Medical, Inc. Over Alleged Securities Fraud

Investors Urged to Take Action Against Picard Medical, Inc.

In a significant move, Levi & Korsinsky, LLP, a prominent law firm specializing in securities litigation, has alerted investors of Picard Medical, Inc. (NYSE: PMI) regarding a class action lawsuit. This legal action aims to address potential losses incurred by shareholders during a precise window from September 2, 2025, to October 31, 2025. Allegations brought forth in the lawsuit suggest that the company's executives may have engaged in securities fraud, leading to misrepresentation and financial loss for investors.

Allegations of Fraudulent Activity

The class action is centered on claims that certain parties within Picard Medical were involved in a fraudulent scheme that manipulated stock prices. The firm asserts that from September to October 2025, misleading statements were made, concealing crucial information regarding the company's financial condition and stock performance. Key allegations include:
1. False Statements and Concealment: It is alleged that the company was part of a fraudulent promotion scheme utilizing social media misinformation and impersonated financial professionals.
2. Insider Trading Practices: Reports indicate that insiders may have engaged in coordinated share dumping, using offshore or nominee accounts to inflate stock prices artificially.
3. Failure to Disclose Risks: The lawsuit claims that Picard Medical neglected to disclose significant risks and the impact of trading activities that artificially inflated the stock price.
4. Materially Misleading Statements: Due to these actions, the company’s representations about its operations and future prospects were deemed materially misleading and not based on a reasonable foundation.

What Investors Should Know

For those who experienced financial loss during the specified period, there is a window until April 3, 2026, to request the Court appoint them as lead plaintiffs in this lawsuit. However, potential recoveries may be made without the obligation of serving as a lead plaintiff.

No Cost to Participate

Levi & Korsinsky emphasizes that participating in this class action carries no out-of-pocket costs. Class members may be eligible for compensation without any financial burden or legal fees, ensuring that interested parties can seek justice without risk.

Why Choose Levi & Korsinsky?

With over 20 years of experience in securities litigation, Levi & Korsinsky has successfully helped numerous shareholders recover substantial funds lost due to corporate misconduct. Their track record speaks volumes, having garnered recognition from various industry reports as one of the top securities litigation firms in the United States. The firm consists of a dedicated team of over 70 professionals focused on delivering results for their clients.

How to Proceed

Investors who believe they are eligible to participate should reach out to Levi & Korsinsky directly. They can provide further information and guide individuals through the process of joining the lawsuit. Interested parties can contact Joseph E. Levi, Esq. directly via email at [email protected] or by phone at (212) 363-7500.

In closing, the ongoing legal battle may serve as an essential step towards accountability and compensation for investors who feel wronged by Picard Medical's actions. Engaging in this class action could provide a pathway not only for recovery but also for increased scrutiny of corporate practices in the medical field.

For more details on the ongoing lawsuit, please visit the link provided by Levi & Korsinsky for further guidance on participation.